In compliance with the provisions of Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and in terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, NGL Fine-Chem has informed that 'Letter of Confirmation' is issued to the following shareholder in lieu of share certificate reported lost by them, as details enclosed. Name of the Shareholder Ashok Kumar Dugar (Folio No. A00369).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1779.40 |
| Dr. Reddys Lab | 1268.75 |
| Cipla | 1376.75 |
| Zydus Lifesciences | 1105.75 |
| Lupin | 2263.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: